Pharmaceutical Use Case #1

Users: Pharmaceutical Company and its key clients, researchers and partners. Around 500 total users.

Background: A Global Pharmaceutical Company manufactures its own drugs and distributes them along with drugs from other companies. As a part of the distribution system, the Company captures information about drug usage. The Company also aggregates and sanitizes the usage information and sells this information to healthcare providers, insurers, researchers and others through a secure Internet site.

The security and privacy of this information is recognized as a primary component of the Company's value proposition. Irreparable harm will result if this information falls into the hands of unauthorized recipients.

The sale of this information provides a significant part of the Company's revenue stream and operates with a very large profit margin. It is also considered to be an important component of the Company's overall value calculation.

Challenge: Management has determined that access controls for authentication and authorization are necessary, but not enough. Between the threat from hackers and the normal turn over in client operations, the company has determined that absolutely unbreakable encryption is required to ensure that even if access to the secure website is compromised, that critical information is still safe.

Objective: To secure sensitive information at rest stored on the Company's website while still allowing secure access to authorized users via the Internet.

Solution: AlphaCipher iAptus

AlphaCipher iAptus allows the Company to distribute critical information to authorized clients and customers in a secure and private environment. Each customer is provided with his or her own, unique encryption key stored on a portable storage device. Only clients who have authorized key on such a device can gain access to the information even if all other authentication and authorization protections fail. At the same time, Management has full control over the distribution and authorization associated with that key.

Annual Revenue from sale of information: $200,000,000
Contribution to corporate valuation: $2 billion (at a 10 multiple)
Cost for unbreakable encryption: < $1,000,000